Sponsor

Threshold Pharmaceuticals

Clinical research sponsor

Published trials4

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

4 shown

Immunotherapy Study of Evofosfamide in Combination With IpilimumabNCT03098160 · lead sponsor · 2017-05-10

UNKNOWN

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid TumorsNCT00743379 · lead sponsor · 2008-08-01

COMPLETED

Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung CarcinomaNCT00435578 · lead sponsor · 2007-02-01

TERMINATED

Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid TumorsNCT00096707 · lead sponsor · 2004-02-01

COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.